Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0564 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0564 | 0.5 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0564 | 0.5 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0564 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0564 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0564 | 0.5 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0564 | 0.5 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0564 | 0.5 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0564 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0564 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0564 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0564 | 0.5 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0564 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0564 | 0.5 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0564 | 0.5 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0564 | 0.5 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0564 | 0.5 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0564 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0564 | 0.5 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0564 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0564 | 0.5 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0564 | 0.5 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0564 | 0.5 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0564 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 210 mg/dl | Antidiabetic activity in mouse 3T3L1 cells assessed as decrease in glucose consumption from cell culture medium using 450 mg/dL D-glucose at 30 ug/mL after 24 hrs (Rvb = 310 +/- 4 mg/dl) | ChEMBL. | 22608392 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.